The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
ESHRE guideline: recurrent pregnancy loss
Open accessAbstract
STUDY QUESTION: What is the recommended management of women with recurrent pregnancy loss (RPL) based on the best available evidence in the literature? SUMMARY ANSWER: The guideline development group formulated 77 recommendations answering 18 key questions on investigations and treatments for RPL, and on how care should be organized. WHAT IS KNOWN ALREADY: A previous guideline for the investigation and medical treatment of recurrent miscarriage was published in 2006 and is in need of an update. STUDY DESIGN, SIZE, DURATION: The guideline was developed according to the structured methodology for development of ESHRE guidelines. After formulation of key questions by a group of experts, literature searches and assessments were performed. Papers published up to 31 March 2017 and written in English were included. Cumulative live birth rate, live birth rate and pregnancy loss rate (or miscarriage rate) were considered the critical outcomes. PARTICIPANTS/MATERIALS, SETTING, METHODS: Based on the collected evidence, recommendations were formulated and discussed until consensus was reached within the guideline group. A stakeholder review was organized after finalization of the draft. The final version was approved by the guideline group and the ESHRE Executive Committee. MAIN RESULTS AND THE ROLE OF CHANCE: The guideline provides 38 recommendations on risk factors, prevention and investigations in couples with RPL, and 39 recommendations on treatments. These include 60 evidence-based recommendations – of which 31 were formulated as strong recommendations and 29 as conditional – and 17 good practice points. The evidence supporting investigations and treatment of couples with RPL is limited and of moderate quality. Of the evidence-based recommendations, only 10 (16.3%) were supported by moderate quality evidence. The remaining recommendations were supported by low (35 recommendations: 57.4%), or very low quality evidence (16 recommendations: 26.2%). There were no recommendations based on high quality evidence. Owing to the lack of evidence-based investigations and treatments in RPL care, the guideline also clearly mentions investigations and treatments that should not be used for couples with RPL. LIMITATIONS, REASONS FOR CAUTION: Several investigations and treatments are offered to couples with RPL, but most of them are not well studied. For most of these investigations and treatments, a recommendation against the intervention or treatment was formulated based on insufficient evidence. Future studies may require these recommendations to be revised. WIDER IMPLICATIONS OF THE FINDINGS: The guideline provides clinicians with clear advice on best practice in RPL, based on the best evidence available. In addition, a list of research recommendations is provided to stimulate further studies in RPL. One of the most important consequences of the limited evidence is the absence of evidence for a definition of RPL. STUDY FUNDING/COMPETING INTEREST(S): The guideline was developed and funded by ESHRE, covering expenses associated with the guideline meetings, with the literature searches and with the dissemination of the guideline. The guideline group members did not receive payment. J.E. reports position funding from CARE Fertility. S.L. reports position funding from SpermComet Ltd. S.M. reports research grants, consulting and speaker’s fees from GSK, BMS/Pfizer, Sanquin, Aspen, Bayer and Daiichi Sankyo. S.Q. reports speaker’s fees from Ferring. The other authors report no conflicts of interest. ESHRE Pages are not externally peer reviewed. This article has been approved by the Executive Committee of ESHRE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Stagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Andrews, J., Guyatt, G., Oxman, A. D., Alderson, P., Dahm, P., Falck-Ytter, Y., Nasser, M., Meerpohl, J., Post, P. N., Kunz, R., et al. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.03.013 · Cited by 1,416
Fibroids and infertility: an updated systematic review of the evidence
Pritts, E. A., Parker, W. H., & Olive, D. L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.051 · Cited by 913
Chan, Y. Y., Jayaprakasan, K., Zamora, J., Thornton, J. G., Raine-Fenning, N., & Coomarasamy, A. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr028 · Cited by 758
Lazarus, J., Brown, R. S., Daumerie, C., Hubalewska-Dydejczyk, A., Negro, R., & Vaidya, B. (2014) · European Thyroid Journal · doi:10.1159/000362597 · Cited by 742
Saravelos, S. H., Cocksedge, K. A., & Li, T.-C. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn018 · Cited by 683
The effect of sperm DNA fragmentation on miscarriage rates: a systematic review and meta-analysis
Robinson, L., Gallos, I. D., Conner, S. J., Rajkhowa, M., Miller, D., Lewis, S., Kirkman-Brown, J., & Coomarasamy, A. (2012) · Human Reproduction · doi:10.1093/humrep/des261 · Cited by 629
Self-citationLashen, H. (2004) · Human Reproduction · doi:10.1093/humrep/deh277 · Cited by 577
Reproductive outcomes in women with congenital uterine anomalies: a systematic review
Chan, Y. Y., Jayaprakasan, K., Tan, A., Thornton, J. G., Coomarasamy, A., & Raine‐Fenning, N. J. (2011) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.10056 · Cited by 564
Research works printed but not linked: 9
- Badawy, 2000, Frequency of etiological factors and cost effectiveness of the work up for patients with history of recurrent pregnancy loss, Early Pregnancy, 4, 253
- Balasch, 1986, The significance of luteal phase deficiency on fertility: a diagnostic and therapeutic approach, Hum Reprod, 1, 145, 10.1093/oxfordjournals.humrep.a136370 · doi:10.1093/oxfordjournals.humrep.a136370
- Calleja-Agius, 2012, Inflammatory cytokines in maternal circulation and placenta of chromosomally abnormal first trimester miscarriages, Clin Dev Immunol, 2012, 175041, 10.1155/2012/175041 · doi:10.1155/2012/175041
- Hofmann, 2000, Recurrent pregnancy loss and diminished ovarian reserve, Fertil Steril, 74, 1192, 10.1016/S0015-0282(00)01626-5 · doi:10.1016/s0015-0282(00)01626-5
- Kodaman, 2007, Intra-uterine adhesions and fertility outcome: how to optimize success?, Curr Opin Obstet Gynecol, 19, 207, 10.1097/GCO.0b013e32814a6473 · doi:10.1097/gco.0b013e32814a6473
- Maryam, 2012, The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals, BMC Res Notes, 5, 133, 10.1186/1756-0500-5-133 · doi:10.1186/1756-0500-5-133
- Prakash, 2006, Absence of follicular phase defect in women with recurrent miscarriage, Fertil Steril, 85, 1784, 10.1016/j.fertnstert.2005.11.045 · doi:10.1016/j.fertnstert.2005.11.045
- Ramanathan, 2016, Multi-modality imaging review of congenital abnormalities of kidney and upper urinary tract, World J Radiol, 8, 132, 10.4329/wjr.v8.i2.132 · doi:10.4329/wjr.v8.i2.132
- Salim, 2011, Diagnosis and management of endometrial polyps: a critical review of the literature, J Minim Invasive Gynecol, 18, 569, 10.1016/j.jmig.2011.05.018 · doi:10.1016/j.jmig.2011.05.018
Cited by
Quenby, S., Gallos, I. D., Dhillon-Smith, R. K., Podesek, M., Stephenson, M. D., Fisher, J., Brosens, J. J., Brewin, J., Ramhorst, R., Lucas, E. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00682-6 · Cited by 1,560
Self-citationDimitriadis, E., Menkhorst, E., Saito, S., Kutteh, W. H., & Brosens, J. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00228-z · Cited by 702
Agarwal, A., Parekh, N., Panner Selvam, M. K., Henkel, R., Shah, R., Homa, S. T., Ramasamy, R., Ko, E., Tremellen, K., Esteves, S., et al. (2019) · The World Journal of Men's Health · doi:10.5534/wjmh.190055 · Cited by 474
ESHRE guideline: recurrent pregnancy loss: an update in 2022
The ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O. B., Elson, J., Kolte, A. M., Lewis, S., Middeldorp, S., Mcheik, S., Peramo, B., Quenby, S., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoad002 · Cited by 417
Self-citationMaas, A. H. E. M., Rosano, G., Cifkova, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E., Lambrinoudaki, I., Maclaran, K., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 344
Metadata
- Authors
- The ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O. B., Elson, J., Kolte, A. M., Lewis, S., Middeldorp, S., Nelen, W., Peramo, B., Quenby, S., Vermeulen, N., & Goddijn, M.
- Venue
- Human Reproduction Open
- Publisher
- Oxford University Press (OUP)
- Published
- 2018
- Volume
- 2018
- Issue
- 2
- Pages
- hoy004-hoy004
- ISSN
- 2399-3529 (ISSN-L)
- OpenAlex
- W2796224907
- Cited by
- 1,002
- References
- 134
- FWCI
- 25.55
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ESHRE guideline: recurrent pregnancy loss. https://app.cochat.ai/papers/10.1093/hropen/hoy004
- The paper
- The ESHRE Guideline Group on RPL, Bender Atik, R., Christiansen, O. B., Elson, J., Kolte, A. M., Lewis, S., Middeldorp, S., Nelen, W., Peramo, B., Quenby, S., Vermeulen, N., & Goddijn, M. (2018). ESHRE guideline: recurrent pregnancy loss. Human Reproduction Open. https://doi.org/10.1093/hropen/hoy004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.